Welcome to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
NB: We use cookies to help personalise your web experience and comply with Irish healthcare law. Whatever your choice, you are agreeing to our use of cookies. Please close this browser tab if you don't want to proceed.
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

May 29, 2016

Cervical Cancer

Download PDF Most cases of cervical cancer are preventable by routine screening with a Pap test (which may be combined with a test for human papillomavirus [HPV]) and by treatment of pre-cancerous lesions. Early detection greatly improves the chances of successful treatment and prevents any early cervical cell changes from becoming cancerous. Women with early […]

Attitudes and Understanding of Cancer Clinical Trials among People with Cancer the Focus of National Study about to be Launched

Details of a new national study ‘Understanding and Attitudes toward Cancer Clinical Research (CCR) among Patients with a Cancer Diagnosis’ were announced on Monday 18th April 2016. The study aims to increase participation rates in Ireland to clinical trials by increasing patients’ understanding of cancer clinical trials. The research is being conducted by All Ireland […]

Hay Fever Policy (Glucocorticoid Injections)

Therapeutic Use Exemption (TUE) Committee Policy on Glucocorticoid Injections for Hay Fever Depo-Medrone (Methylprednisolone) and Kenalog* (Triamcinolone) administered by intra-muscular injection as treatment for hay fever are prohibited in sport and therefore their use requires the athlete and their physician to strictly adhere to the TUE Policy. The TUE Policy is available at www.irishsportscouncil.ie/Anti-Doping/Athlete-Zone/Therapeutic-Use-Exemptions-/   […]

Fingolimod (Gilenya) – Risks related to its immunosuppressive effects

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) recently advised that healthcare professionals and patients be informed of recent product information (Summary of Product Characteristics (SmPC) and Package Leaflet (PL)) changes in relation to the immunosuppressive effect of fingolimod and to reiterate some important recommendations for use. Fingolimod is a sphingosine-1-phosphate receptor modulator, metabolised […]

HPRA commences publication of educational materials and tools for medicines

In December 2015, the HPRA commenced publication of approved educational materials and tools for medicines on its website (www.hpra.ie).   Educational materials are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product. While the approved product information (the Summary of Product Characteristics (SmPC), Package Leaflet (PL) […]

Binosto Once Weekly

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS reimbursable. Sport permitted. Active ingredient: Alendronic acid 70mg (as alendronate sodium trihydrate). Description: White round effervescent tablets. Presentation: 4, €19.64. Indications: Treatment of postmenopausal osteoporosis. Reduces the risk of vertebral and hip fractures. Pharmacology: Alendronate sodium trihydrate is a bisphosphonate that inhibits osteoclastic bone resorption with no […]

Desunin 4000 IU

Company: Meda Health Sales Ireland Ltd. Legal category: Prescription. GMS reimbursable. Sport permitted. Active ingredient: Colecalciferol 4000IU. Description: White to light yellow, oblong tablet with a score line to facilitate breaking for ease of swallowing. Presentation: 70, €19.75. Indication: Treatment of vitamin D deficiency in adults and adolescents. Pharmacology: Vitamin D increases the intestinal absorption […]

Opdivo ▼

Company: Bristol-Myers Squibb Pharmaceuticals. Legal category: Prescription. Hospital only. Sport permitted. Active ingredient: Nivolumab 10mg/ml. Description: Concentrate for solution for infusion in vial. Presentation: 1 x 4ml, 1 x10ml; price available on request. Indications: As monotherapy for treatment of advanced (unresectable or metastatic) melanoma. Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) […]


Company: Biogen Idec Ltd. Legal category: Prescription. High tech. Sport permitted. Active ingredient: Dimethyl fumarate 120mg, 240mg. Description: Green/white or green gastro-resistant hard capsules marked with BG-12 and strength, respectively. Presentation: 120mg-14, €283.00; 240mg-56, €1132.00. Indication: Treatment of relapsing remitting multiple sclerosis. Pharmacology: The mechanism by which dimethyl fumarate exerts therapeutic effects is not fully […]


Company: Sanofi. Legal category: Prescription. GMS reimbursable. Sport prohibited. Active ingredient: Insulin glargine 300 units/ml. Description: Solution for injection in SoloStar pre-filled pen. Presentation: 5 x 1.5ml, €61.61. Indication: Treatment of diabetes mellitus in adults. Pharmacology: Insulin glargine is a human insulin analogue with a low solubility at neutral pH. After injection into subcutaneous tissue, […]

Next Page »